Quality, Innovation, and Value for Money: NICE and the British National Health Service

The National Institute for Health and Clinical Excellence (NICE) was established as a part of the British National Health Service in 1999 to set standards for the adoption of new health care technologies and the management of specific conditions. In doing so it was required explicitly to take into a...

Full description

Saved in:
Bibliographic Details
Published in:JAMA : the journal of the American Medical Association 2005-11, Vol.294 (20), p.2618-2622
Main Authors: Pearson, Steven D, Rawlins, Michael D
Format: Article
Language:English
Subjects:
Academies and Institutes
Cost-Benefit Analysis
Diffusion of Innovation
Drug Evaluation - methods
Health care expenditures
Health care industry
Humans
Innovations
Politics
Quality of Health Care - economics
Quality of Health Care - organization & administration
Quality of service
Quality-Adjusted Life Years
State Medicine - organization & administration
Technology Assessment, Biomedical - methods
Technology Assessment, Biomedical - organization & administration
Treatment Outcome
United Kingdom
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The National Institute for Health and Clinical Excellence (NICE) was established as a part of the British National Health Service in 1999 to set standards for the adoption of new health care technologies and the management of specific conditions. In doing so it was required explicitly to take into account both clinical effectiveness and cost-effectiveness. This article describes how NICE has responded to the challenge and considers whether its experience of balancing quality, innovation, and value for money holds policy lessons for the United States.
ISSN:0098-7484
1538-3598
DOI:10.1001/jama.294.20.2618